Biocon Biologics
Ramprabu Nagarajan has extensive experience in downstream process optimization, technology transfer, and scale-up for manufacturing bio-similar and novel products. Ramprabu has held various positions in companies like Biocon Biologics and Biocon Research Limited, where Ramprabu has led teams, performed scientific evaluations, and presented development activities to support filing of products to regulatory agencies. With a background in Industrial Biotechnology and Chemical Engineering, Ramprabu has demonstrated expertise in process characterization, troubleshooting, and preparation of technical documentation.
This person is not in the org chart
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics